Full Text View
Tabular View
Study Results
Related Studies
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
This study has been completed.
Study NCT00324116   Information provided by Pfizer
First Received: May 8, 2006   Last Updated: November 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial